Fidia Farmaceutica - Fidia Pharma Group
Fidia Farmaceutica - Fidia Pharma Group
Fidia Farmaceutica - Fidia Pharma Group
Fidia Farmaceutica - Fidia Pharma Group
Fidia Farmaceutica - Fidia Pharma Group
Fidia Farmaceutica - Fidia Pharma Group
Fidia Farmaceutica - Fidia Pharma Group

Innovation, quality,
international development, competitiveness.


These are the leading principles of Fidia Farmaceutici S.p.A., an Italian company.


Principles we are committed to deliver, with our people and ideas, approaching the market with a firm grip on reality and developing value-added solutions to healthcare challenges, which is the demand placed on us.



Find out more

Sonno & Salute project

The SONNO & SALUTE project was born thanks to the contribution of Fidia Farmaceutici. It has been developed by sleep scientists...

Find out more
12/06/2018

Sooft is active in the treatment of all major eye conditions through Sooft, Bioos, Glaucoom, OftaH.T. e Neoox trademarks

The company owns 27 patents, further bolstering Fidia Pharma Group’s already strong portfolio, consisting of more than 900 patents, of which over 650 on hyaluronic acid

Abano Terme (PD), June 11, 2018 – Fidia Pharma Group, an Italian multinational company, leader in…
Find out more
25/04/2018

Potential beneficial effect of HYMOVIS® on pain and function

Structural modifying effect in knee OA with HYMOVIS®

Abano Terme, Italy, April 25, 2018 – Fidia Farmaceutici, a world leader in the research, development…
Find out more
19/03/2018

No new drug treatments for primary or recurrent papillary bladder cancer in 15 years

Oncofid®P-B is a Paclitaxel-Hyaluronan Bioconjugate developed and patented by Fidia farmaceutici, a leading Italian pharmaceutical multinational company

Copenhagen, March 18, 2018 – Fidia farmaceutici today announced the positive results from a phase II…
Find out more

Health
Products
Website

Find out more about Fidia’s product portfolio:

Go to the website

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint healthcare
- ophthalmology
- wound care
- dermatology
- neurology
- dermo-aesthetics